The 2023 update emphasizes the importance of early diagnosis and tailored treatment strategies in improving outcomes for patients with heart failure.
Absolute Event Rate: 0% vs 0%
International audience
These new guidelines are generating extensive discussion for lowering the recommended age for TAVI to ≥70 years and emphasizing a 'lifetime management' strategy for valvular heart disease, which significantly alters clinical decision-making and referral patterns.
McDonagh et al. (Fri,) reported a other. The 2023 update emphasizes the importance of early diagnosis and tailored treatment strategies in improving outcomes for patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: